This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for major depressive disorder (MDD) in adolescents aged 12 to
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends that for primary prevention of cardiovascular disease (CVD) in adults a
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends against use of beta carotene or vitamin E supplements for prevention of
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef